Avient (AVNT) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
9 Jul, 2026Executive summary
Sales rose to $815 million in Q3 2024, up 8–8.5% year-over-year, with broad-based growth across all regions and most end markets, led by consumer, packaging, healthcare, defense, and building/construction; telecom and transportation remained weak.
Adjusted EPS increased 14% to $0.65, exceeding guidance, while adjusted EBITDA grew 6% to $130 million; GAAP EPS from continuing operations was $0.41, up from $0.06.
Both Color, Additives and Inks (CAI) and Specialty Engineered Materials (SEM) segments delivered organic revenue growth and margin expansion, supported by market share gains, new product launches, and restocking.
Dividend increased 5% to $1.08 annualized, marking the fourteenth consecutive annual increase.
Refinanced $650 million in senior notes, extending maturity to 2031 at 6.25%, and reduced interest expense through debt paydown and term loan repricing.
Financial highlights
Net sales reached $815 million (+8–8.5% YoY); adjusted EBITDA was $130 million (+6% YoY); adjusted EPS was $0.65 (+14% YoY); gross margin improved to 32.1%.
Operating income for Q3 was $77.2 million, more than double the prior year; net income from continuing operations was $38.2 million.
Adjusted EBITDA margin was 15.9% in Q3 2024, compared to 16.3% in Q3 2023.
Dividend per share for Q3 was $0.2575, up from $0.2475 in the prior year quarter.
Cash and cash equivalents at quarter-end were $505.7 million; liquidity was $739.1 million.
Outlook and guidance
Full-year 2024 adjusted EBITDA guidance narrowed to $525–$530 million; adjusted EPS guidance set at $2.63–$2.67, representing 11–13% growth over prior year.
Q4 adjusted EPS expected in the range of $0.46–$0.50, including a $15 million ($0.12/share) headwind from variable compensation accruals.
Interest expense for the year expected at $104 million; capital expenditures and S/4 Hana investment at ~$140 million.
Management expects sufficient liquidity for the next twelve months and foreseeable future.
Continued strong demand anticipated in consumer, packaging, healthcare, defense, and building/construction; transportation and telecom expected to remain weak.
Latest events from Avient
- 2025 delivered record margins and EPS growth; 2026 guidance targets further gains amid volatility.AVNT
Q4 20259 Jul 2026 - Margin expansion, innovation, and disciplined growth drive strong 2026 outlook.AVNT
Investor presentation4 Jun 2026 - 2026 guidance projects higher margins and EPS, driven by innovation and strong execution.AVNT
Investor presentation14 May 2026 - All voting items passed as 2025 financial targets were met and strategic growth plans outlined.AVNT
AGM 202614 May 2026 - Strong margin expansion and growth guidance driven by innovation and disciplined execution.AVNT
Investor presentation13 May 2026 - Q1 2026 adjusted EPS rose 9% to $0.83, with sales up and margins expanding.AVNT
Q1 20267 May 2026 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.AVNT
Proxy filing27 Mar 2026 - 2026 proxy details innovation-driven strategy, board refresh, and performance-based executive pay.AVNT
Proxy filing27 Mar 2026 - Q2 2024 delivered 21% EPS growth, margin gains, and higher full-year guidance.AVNT
Q2 20242 Feb 2026